Sun Pharmaceutical Industries Ltd
NSE: SUNPHARMA BSE: 524715
₹1825.30
(-0.03%)
Thu, 12 Mar 2026, 10:09 pm
Market Cap4378.44B
PE Ratio40.12
Dividend0.90
Health Technology
Pharmaceuticals: Major
24.5KSun Pharmaceutical Industries Income Statement
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 15.95B | 20.83B | 32.91B | 41.83B | 38.09B | 57.21B | 80.05B | 112.39B | 160.04B | 272.87B | 281.09B | 313.08B | 264.16B | 290.66B | 328.38B | 334.98B | 386.54B | 438.86B | 478.63B | 521.53B |
| Gross profit | 6.17B | 8.72B | 21.46B | 21.74B | 18.77B | 30.44B | 45.73B | 69.20B | 102.87B | 140.26B | 149.95B | 158.65B | 109.05B | 122.52B | 140.94B | 140.85B | 167.31B | 200.19B | 240.83B | 283.81B |
| Operating expenses (excl. COGS) | -1.88B | -2.82B | -6.99B | -4.32B | -8.45B | -12.76B | -16.00B | -23.41B | -33.31B | -71.43B | -74.81B | -73.77B | -67.95B | -73.30B | -88.54B | -75.86B | -86.05B | -109.08B | -145.10B | -159.36B |
| Selling/general/admin expenses, total | — | -2.44B | -4.78B | -3.10B | -8.34B | -11.57B | -15.66B | -23.03B | -32.87B | -69.55B | -72.26B | -71.06B | -65.06B | -71.17B | -83.95B | -71.23B | -79.92B | -101.95B | -139.40B | -152.82B |
| Research & development | -1.54B | -2.44B | -2.79B | -3.10B | -2.08B | -2.86B | -3.89B | -6.25B | -9.37B | -17.38B | -22.24B | -21.46B | -20.52B | -19.06B | -19.25B | -20.97B | -21.23B | -22.26B | -30.42B | -31.34B |
| Selling/general/admin expenses, other | — | — | -1.99B | — | -6.26B | -8.71B | -11.77B | -16.79B | -23.50B | -52.17B | -50.01B | -49.60B | -44.54B | -52.11B | -64.70B | -50.26B | -58.68B | -79.69B | -108.97B | -121.48B |
| Other operating expenses, total | -1.88B | -2.82B | -2.21B | -1.22B | -108.80M | -1.19B | -339.20M | -377.80M | -441.80M | -1.88B | -2.56B | -2.70B | -2.89B | -2.13B | -4.59B | -4.63B | -6.13B | -7.13B | -5.71B | -6.54B |
| Operating income | 4.29B | 5.90B | 14.44B | 17.42B | 10.32B | 17.68B | 29.72B | 45.78B | 69.56B | 68.83B | 75.14B | 84.88B | 41.10B | 49.22B | 52.40B | 64.99B | 81.26B | 91.11B | 95.73B | 124.45B |
| Non-operating income, total | 1.67B | 2.42B | 1.54B | 2.05B | 3.83B | 2.68B | 3.84B | -2.57B | -23.73B | -4.80B | -9.43B | 5.59B | -6.31B | -11.12B | -2.30B | -36.99B | -36.44B | 2.98B | 15.15B | 13.07B |
| Interest expense, net of interest capitalized | -155.60M | -126.80M | -87.60M | -58.50M | -61.50M | -577.30M | -282.00M | -368.90M | -441.90M | -5.79B | -4.69B | -3.56B | -4.25B | -5.21B | -2.51B | -1.19B | -745.90M | -1.47B | -1.92B | -1.64B |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 162.10M | 110.30M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 1.83B | 2.55B | 1.62B | 2.11B | 3.92B | 3.24B | 4.08B | 3.57B | 4.27B | 5.31B | 2.15B | 9.16B | 6.50B | 4.65B | 2.03B | 7.27B | 10.26B | 7.95B | 17.68B | 20.34B |
| Non-operating interest income | 1.02B | 1.20B | 1.23B | 1.28B | 1.20B | 1.92B | 1.98B | 2.37B | 2.06B | 2.56B | 3.57B | 3.71B | 5.20B | 6.69B | 3.27B | 1.72B | 1.48B | 3.42B | 6.93B | 8.79B |
| Miscellaneous non-operating expense | 802.30M | 1.35B | 388.80M | 834.40M | 2.72B | 1.32B | 2.10B | 1.21B | 2.20B | 2.74B | -1.42B | 5.43B | 1.30B | -2.04B | -1.24B | 5.55B | 8.78B | 4.53B | 10.75B | 11.55B |
| Unusual income/expense | -1.20M | — | — | — | -30.80M | 20.40M | 43.00M | -5.77B | -27.55B | -4.32B | -6.89B | -3.80M | -8.55B | -10.57B | -1.82B | -43.07B | -45.95B | -3.50B | -613.80M | -5.63B |
| Pretax income | 5.96B | 8.32B | 15.98B | 19.48B | 14.15B | 20.36B | 33.57B | 43.21B | 45.83B | 64.03B | 65.71B | 90.48B | 34.79B | 38.10B | 50.10B | 27.99B | 44.81B | 94.08B | 110.88B | 137.52B |
| Taxes | -230.50M | 78.00M | -469.10M | -695.90M | -678.60M | -1.28B | -3.13B | -8.46B | -7.02B | -9.15B | -9.14B | -12.12B | -9.11B | -6.01B | -8.23B | -5.15B | -10.76B | -8.48B | -14.39B | -27.72B |
| Non-controlling/minority interest | 2.80M | -558.80M | -640.10M | -602.80M | 41.00M | -913.10M | -3.85B | -4.86B | -7.38B | -9.36B | -11.13B | -8.82B | -4.47B | -5.42B | -4.07B | 6.31B | -1.17B | -393.60M | -336.50M | -357.10M |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 5.73B | 7.84B | 14.87B | 18.18B | 13.51B | 18.16B | 26.58B | 29.90B | 31.43B | 45.39B | 45.46B | 69.64B | 20.96B | 26.65B | 37.65B | 29.04B | 32.73B | 84.74B | 95.76B | 109.29B |
| Net income | 5.73B | 7.84B | 14.87B | 18.18B | 13.51B | 18.16B | 26.57B | 29.83B | 31.41B | 45.39B | 45.46B | 69.64B | 20.96B | 26.65B | 37.65B | 29.04B | 32.73B | 84.74B | 95.76B | 109.29B |
| Dilution adjustment | 0 | 0 | 500.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 900.00K | 900.00K | 500.00K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 5.73B | 7.84B | 14.87B | 18.18B | 13.51B | 18.16B | 26.57B | 29.83B | 31.41B | 45.39B | 45.46B | 69.64B | 20.96B | 26.65B | 37.65B | 29.04B | 32.73B | 84.74B | 95.76B | 109.29B |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 4.90B | 6.71B | 15.44B | 18.66B | 11.82B | 19.72B | 32.64B | 49.15B | 73.65B | 80.78B | 85.52B | 97.53B | 56.10B | 66.75B | 72.92B | 85.79B | 102.69B | 116.40B | 121.30B | 150.21B |
| EBIT | 4.29B | 5.90B | 14.47B | 17.42B | 10.32B | 17.68B | 29.72B | 45.78B | 69.56B | 68.83B | 75.14B | 84.88B | 41.10B | 49.22B | 52.40B | 64.99B | 81.26B | 91.11B | 95.73B | 124.45B |
| Total operating expenses | -11.66B | -14.93B | -18.44B | -24.41B | -27.77B | -39.54B | -50.33B | -66.60B | -90.48B | -204.03B | -205.95B | -228.20B | -223.06B | -241.44B | -275.98B | -269.99B | -305.29B | -347.75B | -382.90B | -397.08B |
| Prepaid expenses | 213.20M | 589.90M | 1.27B | 1.98B | 2.62B | 2.84B | 659.90M | 1.27B | 1.51B | 2.73B | 2.54B | 2.60B | 1.21B | 1.69B | 1.86B | 2.79B | 2.86B | 3.72B | 4.14B | 3.75B |
| Deferred income, current | — | — | — | — | — | — | — | — | 100.30M | 374.50M | 719.10M | 1.22B | 48.40M | 2.21B | 2.24B | 2.14B | 1.93B | 1.57B | 1.27B | 1.34B |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.90M | 2.00M | 2.20M | 662.50M | 662.50M | 997.40M | 997.40M | 2.51B | 2.43B | 5.60B | 5.60B | 3.56B | 3.56B |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 1.14B | 1.55B | 1.82B | 1.23B | 1.53B | 1.76B | 1.84B | 2.15B | 2.89B | 4.94B | 5.14B | 8.16B | 2.19B | 1.04B | 581.40M | 12.00B | 16.13B | 22.77B | 25.84B | 22.92B |
| Deferred income, non-current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 87.80M | 111.90M | 120.70M | 5.59B | 7.59B | 7.19B | 6.19B | 5.70B | 4.89B | 3.77B |
| Minority interest | 331.60M | 437.60M | 1.89B | 1.97B | 1.93B | 8.47B | 11.61B | 16.35B | 19.21B | 28.51B | 40.85B | 37.91B | 38.84B | 33.14B | 38.60B | 30.17B | 30.55B | 33.20B | 34.59B | 2.68B |
| Change in accrued expenses | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | -695.30M | -2.30B | -15.60M | -2.07B | -2.84B | -2.84B | -3.52B | -4.40B | -6.06B | -3.63B | -8.69B | -2.89B | -9.61B | -5.79B | -16.63B | -15.59B | -21.59B | -25.19B | -28.98B | -36.14B |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
